The Aperlena Verdict
Open raceNo supplier dominates: 115 different companies have won the last 190 comparable contracts from this buyer over 5 years. This is a genuinely open race.
- 0%
- Expected final price vs the published estimate
Based on 190 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryThis tender concerns the supply of autoimmunity reagents. The contracting authority is seeking laboratory reagents used in autoimmunity testing, intended to support diagnostic laboratory activities. The procurement covers the purchase and delivery of these reagents according to the requirements set out in the tender documents. The description does not detail quantities, lots or delivery schedules, so bidders should consult the full notice for technical specifications and any arrangements for supply, shelf-life requirements or periodic deliveries. Suppliers of in vitro diagnostic reagents specialising in autoimmune disease testing are the intended audience for this notice.
Official source
Source: BASE - Portal dos Contratos Públicos (IMPIC)
Always verify details on the official notice.
Last verified against BASE - Portal dos Contratos Públicos (IMPIC) 15 hours ago
More from this buyer
Full buyer profile79 open tenders right now
- Accident and health insurance services - Acquisition of insurance services - Work accidents branch 9 days left
- Pharmaceutical products - Purchase of reagents for rapid syndromic diagnostic panels 10 days left
- Road transport services - Acquisition of Passenger Transport Services 18 days left
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| ACCORD HEALTHCARE UNIPESSOAL LDA | 7 | €40,386 | Aug 2026 |
| B.BRAUN MEDICAL, UNIPESSOAL LDA | 6 | €130,657 | Jul 2026 |
| HIKMA FARMACÊUTICA (PORTUGAL) SA. | 6 | €109,376 | Aug 2026 |
| LABESFAL-LAB. ALMIRO, SA. | 6 | €94,364 | Jul 2026 |
| Cardiva Portugal Unipessoal, Lda | 6 | €15,737 | Aug 2026 |
Based on 190 awards with a linked company profile over the last 5 years.
What this buyer has paid before
Based on 190 comparable contracts this buyer awarded in this sector over the last 4 years.
- €2,776
- Lower quartile
- €8,267
- Median award
- €24,405
- Upper quartile
This tender is estimated 267.8% above that median
Most recent awards
- 2026/0449 - Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 2023/0490 (Medicamentos usados em afeções cutâneas), 2023/0491 (Medicamentos do foro oncológico e imunomoduladores), 2023/0492 (Medicamentos anti-infeciosos), 2025/1367 (Medicamentos do aparelho digestivo), 2025/1627 (Medicamentos do aparelho cardiovascular), 2026/0002 (Medicamentos para o sistema nervoso central) €1,392
- 2026/0449 - Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 2023/0490 (Medicamentos usados em afeções cutâneas), 2023/0491 (Medicamentos do foro oncológico e imunomoduladores), 2023/0492 (Medicamentos anti-infeciosos), 2025/1367 (Medicamentos do aparelho digestivo), 2025/1627 (Medicamentos do aparelho cardiovascular), 2026/0002 (Medicamentos para o sistema nervoso central) €18,436
- 2026/0449 - Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 2023/0490 (Medicamentos usados em afeções cutâneas), 2023/0491 (Medicamentos do foro oncológico e imunomoduladores), 2023/0492 (Medicamentos anti-infeciosos), 2025/1367 (Medicamentos do aparelho digestivo), 2025/1627 (Medicamentos do aparelho cardiovascular), 2026/0002 (Medicamentos para o sistema nervoso central) €3,654
- 2026/0449 - Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 2023/0490 (Medicamentos usados em afeções cutâneas), 2023/0491 (Medicamentos do foro oncológico e imunomoduladores), 2023/0492 (Medicamentos anti-infeciosos), 2025/1367 (Medicamentos do aparelho digestivo), 2025/1627 (Medicamentos do aparelho cardiovascular), 2026/0002 (Medicamentos para o sistema nervoso central) €236
- Aquisição do Medicamento Lenvatinib (Kisplyx) 4 mg €5,898
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
Similar tenders
1
day left
€61,903
est. value
1
day left
€180,000
est. value
1
day left
€47,986
est. value
1
day left
€13,800
est. value
1
day left
€110,542
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €9,445,871
- Buyer track record on Aperlena
- 646 notices tracked · 385 awarded
- €12,820,267 in awarded contracts
Never miss a tender like this
17,891 new notices in Medical equipment & pharmaceuticals in Portugal in the last 7 days. Get an email when new ones appear. Free.
Set up my alert